Menu

The Trouble With Sex in Science

Researchers argue for the consideration of hormones and sex chromosomes in preclinical experiments.

Aug 9, 2016
Kerry Grens

PIXABAY, CLIKER-FREE-VECTOR-IMAGESMale animals and male-derived tissues and cells are largely overrepresented in basic science. But in studying mostly male specimens, researchers miss out on an opportunity to understand how hormones and sex chromosomes may impact disease risks and outcomes, according to Deborah Clegg of the Cedars-Sinai Diabetes and Obesity Research Institute and coauthors.

“Researchers are encouraged to critically think of the impact that their experimental design has on the hormonal profile and to accurately analyze the data focusing on the impact of sex, not only of the individual being studied but also of the cell in a dish,” the researchers wrote in Cell Metabolism today (August 9).

Clegg said in a press release that sex considerations go beyond male or female—to, say, whether a woman is postmenopausal or taking birth control pills. “Without addressing all of these variables in your analysis, you’re still not accurately reflecting the impact of hormones and chromosomes in your research.”

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.